Source disclosure: February 05, 2026
HOGY MEDICAL CO.,LTD. [3593.T]
TOKYO, Feb 5 (Reuters) - Hogy Medical Co., Ltd. has announced changes to its previously disclosed support and recommendation regarding TCG2509 Corporation's tender offer for its shares. The company originally issued this statement on December 17, 2025, followed by corrections on December 25, 2025, and January 6, 2026.
According to the announcement, TCG2509 Corporation submitted an amended filing to the Commissioner of the Kanto Regional Finance Bureau following their notification to the Ministry of Finance and relevant authorities via the Bank of Japan under Article 27, Paragraph 1 of the Foreign Exchange and Foreign Trade Law on February 4, 2026. As a result, the tender offer period will be extended from February 5, 2026, until February 20, 2026, marking a total duration of 40 business days.
The revised tender offer aims to fully acquire all shares listed on the Tokyo Stock Exchange Prime Market, excluding self-held treasury stocks and restricted shares held by directors (totaling 10,896 shares, representing 0.05% ownership). This move is part of a broader strategy to integrate Hogy Medical as a wholly-owned subsidiary of TCG2509 Corporation.
In addition, the company emphasizes that measures have been taken to ensure fair competition during the tender process, including setting up evaluation criteria based on enhancing corporate value and maximizing shareholder interests. Furthermore, the tender offer period was initially set at 30 business days, which now extends to 40 business days due to recent regulatory filings.
Regarding compliance with U.S. securities laws, the company notes that while the tender offer adheres to procedures and disclosure standards mandated by Japan’s Financial Instruments and Exchange Act, these may not align with those required under U.S. law, particularly the Securities Exchange Act of 1934. Consequently, non-U.S. residents might face challenges exercising rights derived from U.S. securities regulations against foreign entities involved in the tender offer. All documents related to the tender offer will be primarily in Japanese, with any discrepancies between English and Japanese versions resolved in favor of the Japanese version.
AI-translated content. 🟢 Confidence: High See terms • Original filing